These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12409973)

  • 1. Refractory patterns and susceptibility to drug-induced polymorphic ventricular tachycardias in dogs with chronic atrioventricular block: relation to the type of anesthesia.
    Voss F; Schreiner KD; Senges JC; Becker R; Bauer A; Kuebler W; Schoels W
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):651-9. PubMed ID: 12409973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.
    Weissenburger J; Nesterenko VV; Antzelevitch C
    J Cardiovasc Electrophysiol; 2000 Mar; 11(3):290-304. PubMed ID: 10749352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tridimensional activation patterns of acquired torsade-de-pointes tachycardias in dogs with chronic AV-block.
    Schreiner KD; Voss F; Senges JC; Becker R; Kraft P; Bauer A; Kelemen K; Kuebler W; Vos MA; Schoels W
    Basic Res Cardiol; 2004 Jul; 99(4):288-98. PubMed ID: 15221347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biventricular hypertrophy in dogs with chronic AV block: effects of cyclosporin A on morphology and electrophysiology.
    Schreiner KD; Kelemen K; Zehelein J; Becker R; Senges JC; Bauer A; Voss F; Kraft P; Katus HA; Schoels W
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2891-8. PubMed ID: 15178548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart.
    Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Hansen A; Müller M; Lang HJ; Gerlach U; Busch A; Kraft P; Kübler W; Schöls W
    Circulation; 1999 Nov; 100(21):2184-90. PubMed ID: 10571978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic ventricular tachycardias induced by D-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entry.
    Derakhchan K; Cardinal R; Brunet S; Klug D; Pharand C; Kuś T; Sasyniuk BI
    Cardiovasc Res; 1998 Jun; 38(3):617-30. PubMed ID: 9747430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
    Yamamoto K; Tamura T; Imai R; Yamamoto M
    Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
    Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn Circ J; 2000 Jun; 64(6):445-51. PubMed ID: 10875735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes.
    Volders PG; Sipido KR; Vos MA; Kulcsár A; Verduyn SC; Wellens HJ
    Circulation; 1998 Sep; 98(11):1136-47. PubMed ID: 9736601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs.
    Satoh T; Zipes DP
    Circulation; 1996 Jul; 94(2):217-27. PubMed ID: 8674181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthesia and arrhythmogenesis in the chronic atrioventricular block dog model.
    Dunnink A; Sharif S; Oosterhoff P; Winckels S; Montagne D; Beekman J; van der Nagel R; van der Heyden MA; Vos MA
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):601-8. PubMed ID: 20555233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
    Dobmeyer D; Muir WW; Schaal SF
    J Cardiovasc Pharmacol; 1985; 7(2):238-44. PubMed ID: 2581074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
    Hashimoto K; Haruno A; Hirasawa A; Awaji T; Xue Y; Wu Z
    Jpn J Pharmacol; 1995 May; 68(1):1-9. PubMed ID: 7494370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the I(Kr)-blocking agent dofetilide and of the I(Ks)-blocking agent chromanol 293b on regional disparity of left ventricular repolarization in the intact canine heart.
    Bauer A; Becker R; Karle C; Schreiner KD; Senges JC; Voss F; Kraft P; Kuebler W; Schoels W
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):460-7. PubMed ID: 11862126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heart.
    Takahara A; Nakamura H; Nouchi H; Tamura T; Tanaka T; Shimada H; Tamura M; Tsuruoka N; Takeda K; Tanaka H; Shigenobu K; Hashimoto K; Sugiyama A
    J Pharmacol Sci; 2007 Feb; 103(2):181-8. PubMed ID: 17287589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
    Denniss AR; Richards DA; Taylor AT; Uther JB
    Basic Res Cardiol; 1989; 84(1):5-12. PubMed ID: 2923606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B; Vallin H; Almgren O; Bergstrand R; Insulander P; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.